Journey to relief
Are these troubles weighing you down and disrupting your everyday life?
If these troubles affect your daily life, constipation could be the reason. Find relief from discomfort with one effective constipation solution
Loss of appetite
Bloating & stomach pain
Infrequent bowel movements
Choose Dulcoflex® India’s No.1 brand for constipation
Dulcoflex® provides effective, gentle constipation relief, enabling you to go about your daily activities with no discomfort or interruptions.
Overnight relief
Experience comfort within 6 to 8 hours, making you feel light and refreshed in the morning.
Budget-friendly
Dulcoflex® is a budget-friendly constipation solution, priced at only Rs. 1.25 per tablet.
Gentle formula
Dulcoflex®'s gentle formula effectively relieves constipation, leaving sluggishness and fatigue behind.
Your path to digestive freedom
With Dulcoflex® you can break free from the constraints of constipation and let your ambitions soar.
For more information, visit www.sanofi.in
References:
1. IMS MAT April’23
2. Prescribing Information for Bisacodyl CCDS V1 dated 23rd Apr 2020 sanofi.in/dam/jcr:659be037-3aa9-4c23-bd9d-2791888f9539/Dulcoflex PI_Sep 2021.pdf Accessed on 23rd June 2023
3. National Center for Biotechnology Information. PubChem Compound Summary for CID 2391, Bisacodyl. https://pubchem.ncbi.nlm.nih.gov/compound/Bisacodyl.
4. Levine, Jules, and Seymour H. Rinzler. "Comparison of laxative action of bisacodyl suppositories and glycerin suppositories in acute myocardial infarction∗." The American journal of cardiology 5.1 (1960): 108-110.
5. Wald, A. Is chronic use of stimulant laxatives harmful to the colon? J.Cpn.Gastroenterol. 2003; 36(5):386-389.
6. Wald, A. Constipation in the primary care setting: current concepts and misconceptions. Am.J.Med. 2006; 119(9):736-739.
7. Muller-pssner, S. A. et. al. Myths and misconceptions about chronic constipation. Am.J.Gastroenterol. 2005; 100(1):232-242.
8. Nelson AD, Camilleri M, Chirapongsathorn S, Vijayvargiya P, Valentin N, Shin A, Erwin PJ, Wang Z, Murad MH. Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis. Gut. 2017 Sep;66(9):1611-1622. doi: 10.1136/gutjnl-2016-311835. Epub 2016 Jun 10.
9. Kienzle-Horn, S. et. al. Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-bpnd, randomized, placebo-controlled study. Apment.Pharmacol.Ther. 2006; 23(10):1479-1488.
10. Kienzle-Horn S, Vix JM, Schuijt C, Peil H, Jordan CC, Kamm MA. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. Curr Med Res Opin. 2007 Apr;23(4):691-9. doi: 10.1185/030079907x178865.
11. Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S; American Gastroenterological Association Institute Cpnical Guidepnes Committee. American Gastroenterological Association Institute Guidepne on the Medical Management of Opioid-Induced Constipation. Gastroenterology. 2019 Jan;156(1):218-226. doi: 10.1053/j.gastro.2018.07.016.PMID30340754
12. Package Insert